NCT06728410
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,098 public trials
1,201 recruiting studies
Adenocarcinoma trial results
NCT02471352
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07613151
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- Veneto Institute of Oncology Padova, Italy
NCT05334069
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
NCT06995898
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +64 more
- Locations
-
- Kaiser Permanente-Division of Research Pleasanton, California, United States
- Keefe Memorial Hospital Cheyenne Wells, Colorado, United States
- Kaiser Permanente-Franklin Denver, Colorado, United States
- Poudre Valley Hospital Fort Collins, Colorado, United States
NCT05837767
- Conditions
- Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
NCT07049926
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- UCSF Medical Center at Mission Bay ( Site 5008) San Francisco, California, United States
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5026) Mineola, New York, United States
- Laura and Isaac Perlmutter Cancer Center ( Site 5016) New York, United States
- Memorial Sloan Kettering Cancer Center ( Site 5002) New York, United States
NCT05286814
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +33 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
NCT04981509
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
NCT05964504
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- University of California, San Diego San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
- Abramson Cancer Center Philadelphia, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States